SelectQuote, Inc. (NYSE:SLQT) is mourning the passing of William Thomas "Tom" Grant II, Vice Chairman and former President of the company, who passed away on July 1, 2025, following a battle with cancer. Tom was instrumental in formulating and executing SelectQuote's strategy over the past fifteen years as the business evolved from a term life insurance brokerage into a diversified insurance and rapidly-growing healthcare services business.
SelectQuote's CEO, Tim Danker, stated that "Tom's mark on SelectQuote was profound and cannot be overstated. The success of our company, and the millions of consumers we've helped, are directly attributable to the vision and leadership of Tom Grant." Tom's sons, Bill Grant and Bob Grant, will remain critical members of the SelectQuote executive team going forward, continuing to serve as the company's Chief Operating Officer and President, respectively.
Founded in 1985, SelectQuote has evolved to offer engagement points for consumers across insurance, Medicare, pharmacy, and value-based care. The company now has three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a Patient-Centered Pharmacy Home™ (PCPH) accredited pharmacy, SelectPatient Management, a provider of chronic care management services, and Healthcare Select, which proactively connects consumers with a wide breadth of healthcare services supporting their needs.
The press release did not include specific financial metrics. Following these announcements, the company's shares moved -4.0%, and are now trading at a price of $2.40. For the full picture, make sure to review SelectQuote's 8-K report.
